Health Care/Hospital

DoctorOnCall Partners with Industry Stalwarts to Provide Malaysians Access to Digital Healthcare Amidst COVID-19 Pandemic

KUALA LUMPUR, Malaysia, March 8, 2021 /PRNewswire/ -- DoctorOnCall, Malaysia's first and largest digital health platform today announced partnerships with insurance companies and health industry stalwarts in ensuring that Malaysians are given digital access to healthcare amidst the rising COVID...

2021-03-08 12:02 2620

CMAB Biopharma Congratulates Partner Junshi Biosciences on NMPA Acceptance of Application for a Clinical Trial of its PD-1/TGF-β Bifunctional Fusion Protein

SUZHOU, China, March 7, 2021 /PRNewswire/ -- Recently, CMAB Biopharma (Suzhou) Inc's ("CMAB") partner Shanghai Junshi Biosciences Co., Ltd. ("Junshi Biosciences") (HK: 1877; SH: 688180), announced that a clinical trial application for its PD-1/TGF-β bifunctional fusion protein JS201 injection (J...

2021-03-08 11:41 1470

Ezidebit and Genie Solutions Create a New Way Forward for Medical Consultation Payments

BRISBANE, Australia, March 8, 2021 /PRNewswire/ -- Payments solution provider Ezidebit has been selected byAustralia's leading medical practice management software provider Genie Solutions to provide omni-channel payment options for its customers. This is a first for the medical industry, where p...

2021-03-08 11:31 1660

Dr Ivan Puah notices psychological improvements in patients after undergoing VASER liposuction and fat grafting procedures

SINGAPORE, March 8, 2021 /PRNewswire/ -- Dr. Ivan Puah, an accredited liposuction doctor and Medical Director of Amaris B. Clinic has helped patients address their body fat issues successfully over the past 15 years. This extensive experience provided him with a valuable insight - that the c...

2021-03-08 09:41 1459

Adlai Nortye Announces Formation of its New Scientific Advisory Board

HANGZHOU, China, March 7, 2021 /PRNewswire/ -- Adlai Nortye, a global clinical-stage biopharmaceutical company, today announced the formation of its new Scientific Advisory Board (SAB) comprised of five internationally renowned experts. The SAB includesRonald M. Evans, PhD (Member of the US Natio...

2021-03-08 09:00 1428

Patients Win When Support Is Personalized: New Study From Atlantis Healthcare Shows Treatment Persistence and Adherence Improved by 38%

SYDNEY, March 8, 2021 /PRNewswire/ -- Leading patient outcomes journal Patient Preference and Adherence has published a study that demonstrates significant improvement in treatment behaviors among patients with neovascular age-related macular degeneration (nA...

2021-03-08 08:48 1783

Proxalutamide Phase III Clinical Trial for the Treatment of COVID-19 Patients Approved by FDA

SUZHOU, China, March 5, 2021 /PRNewswire/ -- Kintor Pharmaceutical Limited (HKEX: 9939) is pleased to announce that the Investigational New Drug (IND) application of the phase III clinical trial of Proxalutamide's treatment of male COVID-19 outpatients has been approved by the United States Food ...

2021-03-05 21:00 6858

ABclonal Biotechnology Acquires Yurogen Biosystems to Better Serve Diagnostic and Pharmaceutical Researchers Worldwide

BOSTON, March 5, 2021 /PRNewswire/ -- ABclonal Biotechnology Co., Ltd., a global life science tools and services provider, acquires Yurogen Biosystems LLC, a contract research organization dedicated to monoclonal antibody discovery using single-B-cell-based SMabTM platform, to better serve resea...

2021-03-05 20:00 2600

Top Philippines Ethyl Alcohol Producer Enters U.S. Market with Alcogenix Hand Sanitizers

SAN FRANCISCO, March 5, 2021 /PRNewswire/ -- A top ethyl alcohol producer in the Philippines is set to enter the United States market for hand sanitizers, eyeing bulk buyers such as janitorial supply, retail chains, corporations, city public works departments, schools, hospitals, senior living fa...

2021-03-05 19:55 2438

Soul App Motivates Gen Z to Help People Suffering from Mental Disorders, Injecting Young Energy into Social Good

SHANGHAI, March 5, 2021 /PRNewswire/ -- As a social networking platform that champions a genuine, diverse, and inclusive culture and stands for social good, Soul App has rolled out a series of events for the benefit of the public, especially the vulnerable, and continues to promote to its young u...

2021-03-05 19:00 2641

Elekta and IBA strengthen partnership to help cancer centers integrate proton therapy

STOCKHOLM, March 5, 2021 /PRNewswire/ -- Elekta (EKTA-B.ST) announced today that its latest solution for proton therapy,Monaco®* treatment planning for protons, has received 510(k) clearance from the U.S. Food and Drug Administration.Monaco brings robust functionality for proton therapy, featurin...

2021-03-05 15:19 4862

DFRobot's HuskyLens, an AI Vision Sensor, included in the "forget-me-not" for Alzheimer's patients

SHANGHAI, March 4, 2021 /PRNewswire/ -- Alzheimer's disease is a common syndrome among older people worldwide. InChina, there are about 10 million Alzheimer's patients by now, ranking first in the world. By 2050, the number of Alzheimer's patients inChina is estimated to reach 45 million. Lu Yu...

2021-03-05 14:14 1606

Mayne Pharma launches another generic oral contraceptive

ADELAIDE, Australia, March 4, 2021 /PRNewswire/ -- Mayne Pharma Group Limited (ASX: MYX) is pleased to announce the commercial launch of a generic version of ORTHO-CEPT® (desogestrel and ethinyl estradiol 0.15 mg / 0.03 mg) tablets to customers in the US. This is the fourth oral contraceptive la...

2021-03-05 05:34 4413

Oxford Immunotec Submits Emergency Use Authorization Request to the FDA and CE Marks T-SPOT®.COVID, a Test for the Detection of a Cell Mediated (T cell) Immune Response to SARS-CoV-2 Infection

OXFORD, United Kingdom and MARLBOROUGH, Mass., March 5, 2021 /PRNewswire/ -- Oxford Immunotec Global PLC (Nasdaq: OXFD) (the "Company"), a global, high-growth diagnostics company, announced that today it has released the T-SPOT.COVID test, a CE marked ELISPOT based test intended for qualitative ...

2021-03-05 04:01 4870

Foresee Pharmaceuticals Enters Exclusive License Agreement with Intas Pharmaceuticals for Commercialization in the United States

TAIPEI, March 4, 2021 /PRNewswire/ -- Foresee Pharmaceuticals (6576.TWO) ("Foresee") announced today that it has entered into an exclusive license agreement with Intas Pharmaceuticals ("Intas") for the US commercialization of Foresee's novel FP-001 program, Leuprolide Mesylate Injectable Suspensi...

2021-03-04 23:00 2626

Lunit Announces Partnership to Incorporate its Chest Detection Suite into Philips' Diagnostic X-ray Suite

SEOUL, South Korea, March 4, 2021 /PRNewswire/ -- Lunit , a leading medical AI startup, today announced its partnership withPhilips . Announced during the  European Congress of Radiology (ECR)

2021-03-04 17:00 1444

Zymo Research Offers Community-Wide SARS-CoV-2 Detection and Variant Tracking with the Environ™ COVID-19 Wastewater Testing Service

IRVINE, Calif., March 4 2021 /PRNewswire/ -- Zymo Research announced today the launch of itsEnviron™ COVID-19 Wastewater Testing Service. This service facilitates daily community-wide monitoring of COVID-19 cases and variants from a single wastewater sample. Daily case estimates and detected SARS...

2021-03-04 14:33 2764

MedAlliance Receives Fourth FDA Breakthrough Device Designation for Sirolimus Drug-Eluting Balloon in Treatment of De Novo Coronary Lesions

NYON, Switzerland, March 4, 2021 /PRNewswire/ -- MedAlliance, the first drug-eluting balloon (DEB) company in the world to receive US Food and Drug Administration (FDA) Breakthrough Device Designation Status for a sirolimus DEB, has now been awarded breakthrough status for SELUTION SLR™, its sust...

2021-03-04 09:00 2487

Medical expert warns thousands could die from HPV programming interrupted by Covid-19

LONDON, March 4, 2021 /PRNewswire/ -- On HPV Awareness Day, the International Papillomavirus Society is urging women to attend delayed cervical screenings and for all interrupted services to re-start as thousands continue to miss out on vital HPV care, with deadly consequences. The IPVS is also c...

2021-03-04 08:01 1947

Founder of NutriBullet®* Launches Wellness Brand - Beast Health™ - and its Design-Forward Blender and Hydration System

Groundbreaking Product is First of Several Planned Launches from Beast Health, LLC LOS ANGELES, March 3, 2021 /PRNewswire/ -- Colin Sapire, founder of the NutriBullet®* and innovator behind personal blending products for more than a decade, announces the launch of wellness brand Beast Healt...

2021-03-03 23:02 1928
1 ... 549550551552553554555 ... 808